Durbin
  • Managed Access Programs
  • Imports (Unlicensed Medicines)
  • International Sales
  • Clinical Trial Supply
  • Bespoke Specialist Distribution
  • Sales to NGOs & Charities
  • Sexual Health Supplies
  • Durbin USA
  • About Us
  • News
  • Contact Us
  • News

    Durbin drives exciting US expansion with landmark acquisition

    01 December 2014

    In an exciting move on 1st December 2014, The Durbin Group acquired Pharmaceutical Trade Services Inc. (PTSI) from UDG Healthcare PLC.

    PTSI is an established US-based pharmaceutical supplier, which has been in operation for over 15 years. They specialise in supplying US pharmaceutical, OTC and nutritional supplement products not yet licensed in the importing country, including controlled substances, temperature-controlled products and hazardous materials. Products are supplied to importers on a named-patient basis and on authorisation from the importing country's Ministry of Health.

    PTSI liases between US manufacturers and clinical trial facilities that require a supply of pharmaceutical products for clinical studies.

    This landmark acquisition cements Durbin’s position as one of the world’s leading global pharmaceutical specialist distributors.

    Durbin helps patients in need get vital medications in a number of sectors ranging from International Sales, Charity & NGO supply, pre-registration medications and shortages. Durbin has a truly international presence built up over 50 years where it delivers pharmaceuticals, ancillaries and medical devices to over 180 different countries.

    Durbin’s CEO Leslie Morgan OBE DL comments:

    “We are very excited about this recent acquisition and look forward to offering our customers an even wider sourcing network, better prices on US stock and extended customer service hours. PTSI shares Durbin’s philosophy in providing excellent support for both employees and customers and we are delighted to be welcoming our American colleagues to the Durbin Team”.

    Durbin continues to provide a range of over 22,000 products to its client base, which includes some of the world’s largest pharmaceutical companies, the UK NHS, multilateral agencies and healthcare professionals throughout the world. The recent PTSI acquisition will now mean that Durbin has logistics, customer service, operations and warehousing teams in both the US and UK, further strengthening the firm’s international capabilities.

    For further information about this story please email marketing@durbin.co.uk

    Press Releases